Ardent Health to Participate in Upcoming Investor Conferences

BRENTWOOD, Tenn.--(BUSINESS WIRE)-- Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing midsize urban communities across the U.S., today announced that members of the Company’s management team will participate in the following upcoming investor conferences:

• Stephens Annual Investment Conference on Tuesday, November 19, in Nashville, Tennessee. Members of the management team will participate in a fireside chat discussion at 10:00 a.m. ET that same day.
• Citi 2024 Global Healthcare Conference on Tuesday, December 3, in Miami, Florida.
• Bank of America Securities Leveraged Finance Conference on Wednesday, December 4, in Boca Raton, Florida.

A live audio webcast of the fireside chat discussions will be available at the Investor Relations section of the Company’s website, at https://ir.ardenthealth.com, and a replay will be available for 90 days using the same link.

In conjunction with these conferences, the Ardent Health management team will be available to participate in one-on-one meetings with investors registered to attend each conference. For more information, please contact your sales representative at the host firm, or Dave Styblo, Ardent Health’s senior vice president of investor relations at [email protected].

About Ardent Health

Ardent Health (NYSE: ARDT) is a leading provider of healthcare in growing mid-sized urban communities across the U.S. With a focus on people and investments in innovative services and technologies, Ardent is passionate about making healthcare better and easier to access. Through its subsidiaries, the Company delivers care through a system of 30 acute care hospitals and more than 200 sites of care with over 1,700 affiliated providers across six states. For more information, please visit www.ardenthealth.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241105987820/en/

Investor Contact:
Dave Styblo
[email protected]
(615) 296-3016

Media Contact:
Rebecca Kirkham
[email protected]
(615) 296-3635

Source: Ardent Health

You May Also Be Interested In

• Vitruvias Therapeutics, Inc. Issues Nationwide Recall of One Lot of Thyroid Tablets, USP 30 mg Due to Potential Super Potency
• Momentus Grants Inducement Awards to New Employees
• PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and Approximately 18% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti,